Champix

* For illustration purpose only
Champix
Short description
Champix 0.5mg 30 pills 30 pills
5,137.18 SEK
Champix 0.5mg 60 pills 60 pills
8,405.30 SEK
Champix 0.5mg 90 pills 90 pills
11,673.42 SEK
Champix 0.5mg 120 pills 120 pills
14,941.54 SEK
Champix 0.5mg 180 pills 180 pills
21,488.71 SEK
Champix 0.5mg 240 pills 240 pills
28,024.95 SEK
Champix 0.5mg 270 pills 270 pills
33,162.13 SEK
Champix 0.5mg 360 pills 360 pills
42,966.49 SEK

added to cart
-
Shippingavrg. 5-9 daysGuaranteed delivery time 16 daysGuaranteed delivery time 16 days
-
Payment
-
Upgrade and save. Add worth of items to cart and get free shipping
2186.03 SEK
Champix
Commercial Name: Champix
Principal Ingredient: Varenicline
Utilization: Quitting Tobacco
Available Dosage: 0.5mg
Champix Overview
Champix is intended for the treatment of nicotine addiction. Champix has high binding affinity and selectivity. Nicotine is intensely bound to a similar receptor site to which Champix has a higher binding affinity. Due to the use of Champix, the craving for smoking is reduced and the manifestation of withdrawal symptoms is facilitated.
At the same time, the feeling of pleasure from smoking decreases (antagonism in the presence of nicotine). According to clinical studies, Champix has a statistically significant advantage over bupropion. Additionally, Champix significantly reduces the effects of reinforcement that occur during smoking and can reinforce the habit of smoking in patients who smoke during therapy.
Patients who do not want or cannot set a goal to quit smoking for 1–2 weeks may be asked to start therapy with the option to choose their own smoking cessation date within a range of 5 weeks. Patients who previously tried to quit smoking using Champix and who received Champix treatment repeatedly, compared with placebo, have the best level of proven persistent abstinence.
The biotransformation of Champix is minimal: only 92% of the dose is excreted unchanged by the kidneys, less than 10% as metabolites.
Kidney removal is mainly carried out by glomerular filtration in combination with active tubular secretion. The pharmacokinetic processes of Champix do not significantly depend on status, age, sex, race, or concomitant therapy of a person.